Search Hotels in Sausalito

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 14, 2023

Via Benzinga

Analyst Ratings for BioNTech ↗

November 14, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

Is BioNTech Stock a Buy Now? ↗

October 25, 2023

Or is it too late to get in on the company after its coronavirus-related success?

Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million...

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal ↗

November 11, 2023

Via Talk Markets

Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review ↗

November 10, 2023

The major indexes ended long win streaks. Datadog led earnings winners.

With questions rising about the economy, investors may consider undervalued biotech stocks for their relative insulation factor.

7 Underappreciated Biotech Stocks to Pick Up on the Cheap ↗

November 09, 2023

BNTX earnings call for the period ending September 30, 2023.

Topics Economy

Mohamed El-Erian On Yield And Oil Price Drop: Economic Boon Or Major Downturn Ahead? ↗

November 07, 2023

Via Benzinga

BioNTech Se (BNTX) Q3 2023 Earnings Call Transcript ↗

November 06, 2023

Eli Lilly jumped, while energy plays were big winners and losers.

Topics Earnings

Eli Lilly, Power Generators Lead Top S&P 500 Performers Monday ↗

November 06, 2023

The company was expected to report a third-quarter loss and plummeting sales.

Topics Stocks

BioNTech Stock Surges On Surprise Profit, Strong Sales. But Report Has Downside. ↗

November 06, 2023

U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 40 points on Monday The Dow traded up 0.13% to 34,106.99 while the NASDAQ rose 0.16% to 13,499.42. The S&P 500 also...

Crude Oil Moves Higher; BioNTech Lowers 2023 Sales Outlook ↗

November 06, 2023

Via Benzinga

Topics Stocks

Like Moderna, BioNTech Cuts Annual Sales Forecast By 20% As Pandemic Fades ↗

November 06, 2023

BioNTech SE (NASDAQ: BNTX) has reported Q3 revenues of €895.3 million ($974.49 million), sharply down from €3.461 billion a year ago.

Via Benzinga

US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields ↗

November 06, 2023

The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly from the small and mid-cap space.

Via Benzinga

Topics Economy

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update

November 06, 2023

From BioNTech SE

The company issued below-consensus sales views for 2023 and 2024.

Moderna Beats Sales Forecasts, But Light Guidance Could Rattle Shares ↗

November 02, 2023

A couple of these stocks might not be available for under $100 for too much longer.

3 No-Brainer Stocks to Buy for Under $100 Right Now ↗

October 28, 2023

With many investors concerned about what may lie ahead in the market, these potentially de-risked undervalued stocks may be ideal.

7 Undervalued Stocks That Analysts Love Right Now ↗

October 26, 2023

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19

October 26, 2023

From Pfizer Inc.

Via Business Wire

Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19

October 26, 2023

From BioNTech SE

BioNTech Presents Positive Phase 1/2 Data Update for CAR-T Cell Therapy Candidate BNT211 in Advanced Solid Tumors at ESMO Congress 2023

October 23, 2023

From BioNTech SE

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END

Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

October 23, 2023

Via FinancialNewsMedia

BioNTech to Report Third Quarter Financial Results and Corporate Update on November 6, 2023, And to Host Innovation Series Day on November 7, 2023

October 23, 2023

From BioNTech SE

The venerable pharmaceutical companies' shares have slumped this year.

Which Is the Better Long-Term Hold for Investors: Pfizer or Roche? ↗

October 21, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:BNTX),(NASDAQ:SGEN),(NASDAQ:MYGN),(NASDAQ:ILMN) EQNX::TICKER_END

Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research

October 20, 2023

Via FinancialNewsMedia

Pfizer Reportedly Hikes Paxlovid Price To $1,390 — More Than Double What The Government Paid ↗

October 19, 2023

The transition to the commercial market is planned for 2024 and could bolster sales.

There's always a bear market somewhere. Here are seven stocks to sell that investors should definitely unload now.

7 Stocks That Are Heading for a Train Wreck ↗

October 19, 2023